Search Within

Dean Bajorin

Formats
  1. Journal Article (346)
  2. Meeting Abstract (283)
  3. Book Section (17)
  4. Correspondence (6)
  5. Conference Paper (5)
  6. Review (3)
  7. Book Whole (1)
  8. Editorial (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (663)
  2. Genitourinary Oncology Service (663)
  3. Solid Tumor Oncology Division (663)
  4. Surgery (283)
  5. Urology (273)
  6. Survivorship Research (233)

More Groups

People
  1. Jonathan Rosenberg (205)
  2. Gopakumar Iyer (164)
  3. Hikmat Al-Ahmadie (150)
  4. George Bosl (147)
  5. Bernard Bochner (141)
  6. David Solit (130)

More People

Years
  1. 2025 (12)
  2. 2024 (15)
  3. 2023 (17)
  4. 2022 (29)
  5. 2021 (32)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (270)
  2. Annals of Oncology (27)
  3. Cancer (26)
  4. Journal of Urology (25)
  5. Modern Pathology (19)
  6. Laboratory Investigation (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (280)
  2. Elsevier Science, Inc. (59)
  3. Elsevier Inc. (51)
  4. American Association for Cancer Research (40)
  5. Wiley Blackwell (40)
  6. Oxford University Press (35)

More Publishers

Results (663)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High dose intravenous (IV) cisplatin (C) with sodium thiosulfate (STS) renal protection
    Meeting Abstract

    Markman, M.; Iannotti, N.; D'Acquisto, R.; Hakes, T.; Bajorin, D.; Kris, M.; Bosl, G.; Casper, E.; Reichman, B.; Magill, G.
    Clinical Research (1988)

    Fulltext@MSK | Save
  • High-dose cisplatin in elderly patients - Reply
    Journal Article

    Bajorin, D. F.
    Journal of Clinical Oncology (1988)

    Fulltext@MSK | Save
  • A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors
    Journal Article

    Bosl, G. J.; Geller, N. L.; Bajorin, D.; Leitner, S. P.; Yagoda, A.; Golbey, R. B.; Scher, H.; Vogelzang, N. J.; Auman, J.; Carey, R.; more...
    Journal of Clinical Oncology (1988)

    Fulltext@MSK | Save
  • Identification and management of poor risk patients with germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Bosl, G. J.; Geller, N. L.; Bajorin, D.
    Seminars in Oncology (1988)

    Fulltext@MSK | Save
  • Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies
    Journal Article

    Bajorin, D.; Katz, A.; Chan, E.; Geller, N.; Vogelzang, N.; Bosl, G. J.
    Journal of Clinical Oncology (1988)

    Fulltext@MSK | Save
  • Pharmacokinetics, biodistribution and radiolocalization of (131)I-labeled mouse monoclonal antibody (MAb) R24
    Meeting Abstract

    Bajorin, D.; Yeh, S.; Wong, G.; Dantis, L.; Vadhan, S.; Coit, D.; Templeton, M.; Lloyd, K. O.; Oettgen, H. F.; Old, L. J.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1987)

    Fulltext@MSK | Save
  • High dose intravenous cisplatin (DDP) with simultaneous intravenous sodium thiosulfate: A preliminary report
    Meeting Abstract

    Markman, M.; D'Acquisto, R.; Hakes, T.; Bajorin, D.; Kris, M.; Magill, G.; Bosl, G.
    Clinical Research (1987)

    Fulltext@MSK | Save
  • Phase I trial of escalating doses of cisplatin in hypertonic saline
    Journal Article

    Bajorin, D.; Bosl, G. J.; Fein, R.
    Journal of Clinical Oncology (1987)

    Fulltext@MSK | Save
  • An analysis of poor risk assignment in patients with germ cell tumours
    Journal Article

    Bosl, G. J.; Bajorin, D.; Geller, N. L.
    International Journal of Andrology (1987)

    Fulltext@MSK | Save
  • Phase II trial of mitomycin in malignant mesothelioma
    Journal Article

    Bajorin, D.; Kelsen, D.; Mintzer, D. M.
    Cancer Treatment Reports (1987)

    Fulltext@MSK | Save